AK

Ashok Kumar

Active Director Director DIN 03381197
DIN 03381197 First appointment Jan 2011 Primary industry Metals and Minerals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2011
Shareholding value •••• Premium profile

About Ashok Kumar

Data last updated:

Ashok Kumar is a Director at N B Pharma Private Limited (since 2011). The company operates in Metals and Minerals. N B Pharma Private Limited reported revenue of ₹1.74 Cr (FY 2024).

DIN 03381197
Primary Designation Director
Industry Metals and Minerals
First Appointment 19 Jan 2011
Oldest Company Age 24 yrs
Largest company N B Pharma Private Limited · ₹1.74 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
N B Pharma Private Limited U24239HR2002PTC034813
Director19 Jan 20112002₹1.74 Cr (FY 2024)Active

Board colleagues of Ashok Kumar

NameDINCompanyDesignation
Rishu Bansal03381174N B Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
N B Pharma Private Limited
Premium access

Shareholding and investment profile for Ashok Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ashok Kumar

Ashok Kumar currently holds 1 directorship: N B Pharma Private Limited (Director, since 19 Jan 2011, revenue ₹1.74 Cr (FY 2024)).

Ashok Kumar was first appointed on 19 Jan 2011 as Director at N B Pharma Private Limited.

The current boards of Ashok Kumar's companies include Rishu Bansal (N B Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available